Tandem Diabetes director reports RSU grant and vesting
Tandem Diabetes Care director Peyton R. Howell reported equity award activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tandem Diabetes Care director Peyton R. Howell reported equity award activity. On May 21, 2026, 8,759 previously granted restricted stock units vested and were exercised into the same number of common shares, increasing direct holdings to 29,836 shares. On May 20, 2026, Howell also received a new grant of 10,220 restricted stock units under the company’s 2023 Long-Term Incentive Plan, which will vest on the one-year anniversary of the grant date.
Insider Trade Summary
8,759 shares exercised/converted
Exercise
3 txns
Insider
Howell Peyton R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 8,759 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,759 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 10,220 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 10,220 contracts (Direct);
Common Stock — 29,836 shares (Direct)
Footnotes (3)
- F1. Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F2. Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
- F3. On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Key Figures
RSUs vested and converted: 8,759 shares
RSU grant size: 10,220 units
Shares held after transaction: 29,836 shares
+2 more
5 metrics
RSUs vested and converted
8,759 shares
Restricted stock units converting into common stock on May 21, 2026
RSU grant size
10,220 units
New restricted stock unit grant on May 20, 2026
Shares held after transaction
29,836 shares
Direct common stock holdings following transactions
RSU conversion price
$0.00 per unit
Exercise/conversion price for vested restricted stock units
Total acquire-type transactions
3 transactions
Form 4 summary of acquire-direction events
Key Terms
Restricted Stock Unit, Long-Term Incentive Plan, derivative security, grant, award, or other acquisition
4 terms
Restricted Stock Unit financial
"Each restricted stock units (RSU) represents a contingent right to receive either one share..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Long-Term Incentive Plan financial
"in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan..."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Tandem Diabetes Care (TNDM) report for Peyton R. Howell?
Peyton R. Howell reported equity award-related acquisitions. 8,759 restricted stock units vested and converted into common stock on May 21, 2026, and 10,220 new restricted stock units were granted on May 20, 2026, under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan.
What restricted stock unit grant did Tandem Diabetes Care (TNDM) give Peyton R. Howell?
Howell received a grant of 10,220 restricted stock units on May 20, 2026. Each unit represents a contingent right to one share of common stock or cash, at the company’s discretion, under the 2023 Long-Term Incentive Plan.
When will Peyton R. Howell’s new Tandem Diabetes Care (TNDM) RSUs vest?
The 10,220 restricted stock units granted to Howell will vest one year after May 20, 2026. Vesting is subject to the terms of Tandem Diabetes Care’s 2023 Long-Term Incentive Plan and the related award agreements.
What happened to the 8,759 Tandem Diabetes Care (TNDM) RSUs previously granted to Peyton R. Howell?
The 8,759 restricted stock units previously granted to Howell fully vested and converted into common stock. According to the disclosure, this vesting and conversion occurred on the one-year anniversary of the original grant, consistent with the 2023 Long-Term Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates